>In this and other Dry AMD posts you seem to suggest that treating the Dry form (as opposed to preventing the progression to Wet) is not a significant opportunity.<
I think it is a significant opportunity, but it’s an opportunity with an especially high hurdle for safety and tolerability due to the slow-progressing nature of the disease.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.